Germacrone mitigates cardiac remodeling by regulating PI3K/AKT-mediated oxidative stress, inflammation, and apoptosis

Area of Science:

• Cardiovascular Research
• Pharmacology
• Molecular Biology

Background:

• Cardiac remodeling is a significant consequence of cardiovascular diseases, closely linked to oxidative stress, inflammation, and apoptosis.
• Germacrone, a bioactive compound from Rhizoma curcuma, exhibits known anti-oxidative, anti-inflammatory, and anti-apoptotic properties.

Purpose of the Study:

• To investigate the protective effects of germacrone against isoproterenol (ISO)-induced cardiac remodeling.
• To elucidate the underlying molecular mechanisms of germacrone's cardioprotective action.

Main Methods:

• In vivo study using C57BL/6 mice subjected to ISO injection and germacrone treatment.
• In vitro study utilizing neonatal rat cardiomyocytes (NRCMs) to assess ISO-induced cardiac injury.
• Analysis of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pathway activation.

Main Results:

• ISO administration induced significant oxidative stress, inflammation, and apoptosis in cardiac tissues and cardiomyocytes.
• Germacrone treatment markedly attenuated these ISO-induced detrimental effects, mitigating myocardium remodeling and improving cardiac function.
• Germacrone inhibited the activation of the PI3K/AKT pathway, and blocking this pathway abrogated germacrone's protective effects.

Conclusions:

• Germacrone demonstrates significant cardioprotective effects against cardiac remodeling by attenuating oxidative stress, inflammation, and apoptosis.
• The mechanism involves the inhibition of the PI3K/AKT signaling pathway.
• Germacrone represents a promising therapeutic candidate for treating cardiac remodeling associated with cardiovascular diseases.